Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
{{output}}
Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two-treatment-period, drug-drug interaction study evaluated the effect of steady-state asciminib on t... ...
